BDNF/NT 3 Growth Factors Receptor – Pipeline Review, H1 2016 : Market Insights, Regional Outlook And Forecasts – Acute Market Reports

Global Markets Direct’s, ‘BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) – Pipeline Review, H1 2016’, provides in depth analysis on BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or […]

» Read more

MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 : Market Size, Key Players, Competitive Strategies and Forecasts – Acute Market Reports

Acute Market Reports, ‘MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 (Mitogen Activated Protein Kinase-Interacting Kinase 2 or MAP Kinase Signal-Integrating Kinase 2 or EC 2.7.11.1) – Pipeline Review, H1 2016’, provides in depth analysis on MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 (Mitogen Activated Protein Kinase-Interacting Kinase 2 or MAP Kinase Signal-Integrating Kinase 2 or EC 2.7.11.1) targeted pipeline therapeutics. Browse Full Report Visit […]

» Read more

Cyclin-Dependent Kinase 5 – Pipeline Review, H1 2016 : Market Size, Share, Trend, Growth, Analysis and Forecast – Acute Market Reports

Acute Market Reports, ‘Cyclin-Dependent Kinase 5 (Serine/Threonine-Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or EC 2.7.11.22) – Pipeline Review, H1 2016’, provides in depth analysis on Cyclin-Dependent Kinase 5 (Serine/Threonine-Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or EC 2.7.11.22) targeted pipeline therapeutics. Browse Full Report Visit – http://www.acutemarketreports.com/report/cyclin-dependent-kinase-5-serinethreonine-protein-kinase-pssalre-or-tau-protein-kinase-ii-catalytic-subunit-or-ec-271122-pipeline-review-h1-2016 The report provides comprehensive information on […]

» Read more

Formaldehyde Dehydrogenase Pipeline Review, H1 2016 : Size, Share, Trend, Growth, Analysis and Forecast Report 2016 – Acute Market Reports

Acute Market Reports, ‘Formaldehyde Dehydrogenase (S-Nitrosoglutathione Reductase or NAD-Dependent Formaldehyde Dehydrogenase or EC 1.2.1.46) – Pipeline Review, H1 2016’, provides in depth analysis on Formaldehyde Dehydrogenase (S-Nitrosoglutathione Reductase or NAD-Dependent Formaldehyde Dehydrogenase or EC 1.2.1.46) targeted pipeline therapeutics. Browse Full Report Visit – http://www.acutemarketreports.com/report/formaldehyde-dehydrogenase-s-nitrosoglutathione-reductase-or-nad-dependent-formaldehyde-dehydrogenase-or-ec-12146-pipeline-review-h1-2016 The report provides comprehensive information on the Formaldehyde Dehydrogenase (S-Nitrosoglutathione Reductase or NAD-Dependent Formaldehyde Dehydrogenase or […]

» Read more

Alpha-N-Acetylglucosaminidase – Pipeline Review, H1 2016 : Market Size, Growth, Trends, Industry Analysis and Forecast – By Acute Market Reports

Acute Market Reports, ‘Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) – Pipeline Review, H1 2016’, provides in depth analysis on Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50) targeted pipeline therapeutics. Browse Full Report Visit – http://www.acutemarketreports.com/report/alpha-n-acetylglucosaminidase-n-acetyl-alpha-glucosaminidase-or-nag-or-ec-32150-pipeline-review-h1-2016 The report provides comprehensive information on the Alpha-N-Acetylglucosaminidase (N-Acetyl-Alpha-Glucosaminidase or NAG or EC 3.2.1.50), targeted therapeutics, complete with analysis by indications, stage of development, […]

» Read more

NT 3 Growth Factor Receptor – Pipeline Review, H1 2016 : Market Size, Share, Trends, Growth and Forecast – Acute Market Reports

Acute Market Reports, ‘NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) – Pipeline Review, H1 2016’, provides in depth analysis on NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) targeted […]

» Read more
1 30 31 32 33 34 72